IMCR – immunocore holdings plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Enodia Therapeutics Appoints Dr. Yvonne McGrath as Chief Scientific Officer to Accelerate Upstream Targeted Protein Degradation Platform
Immunocore (IMCR) had its "buy" rating reaffirmed by HC Wainwright. They now have a $100.00 price target on the stock.
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
A Look At Immunocore (IMCR) Valuation After Jefferies Downgrade And Kimmtrak Growth Concerns [Yahoo! Finance]
Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer [Yahoo! Finance]
Form ARS Immunocore Holdings plc For: Dec 31
Form DEF 14A Immunocore Holdings plc For: May 27
Form 144 Immunocore Holdings plc Filed by: Berman David M
Form 144 Immunocore Holdings plc Filed by: Berman David M
Form SCHEDULE 13G/A Immunocore Holdings plc Filed by: T. Rowe Price Investment Management, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.